Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 28, Issue 4, Pages 765-769Publisher
IOS PRESS
DOI: 10.3233/JAD-2011-111502
Keywords
Alzheimer's disease; GABA; glutamate; neuron-glia trafficking; neurotransmitter cycle; nuclear magnetic resonance spectroscopy
Categories
Funding
- Department of Biotechnology, India
Ask authors/readers for more resources
Preclinical diagnosis of Alzheimer's disease is a major challenge. The present study evaluates glutamatergic and GABAergic neurotransmitter energetics at the age of 6 months in A beta PPswe-PS1dE9 mouse model of Alzheimer's disease by using H-1-[C-13]-NMR spectroscopy together with infusion of [1,6-C-13(2)] glucose. NMR analysis suggested no significant derangement in neurochemical profile in A beta PPswe-PS1dE9 mice. However, decrease in labeling of glutamate-C4, GABA-C2 and glutamine-C4 at early infusion-time together with no change in labeling at steady state from [1,6-C-13(2)] glucose indicates an impaired glutamatergic and GABAergic glucose oxidation and neurotransmitter cycle in A beta PPswe-PS1dE9 mice. These findings may have implication in preclinical diagnosis of Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available